Skip to main content

ESP 818 (Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg)

Generic Name: bempedoic acid/ezetimibe

Pill with imprint ESP 818 is Blue, Elliptical / Oval and has been identified as Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg. It is supplied by Esperion Therapeutics, Inc..

Nexlizet is used in the treatment of high cholesterol, familial heterozygous and belongs to the drug class antihyperlipidemic combinations. Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ESP 818

Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg ESP 818

Nexlizet

Generic Name
bempedoic acid/ezetimibe
Imprint
ESP 818
Strength
bempedoic acid 180 mg / ezetimibe 10 mg
Color
Blue
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antihyperlipidemic combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Esperion Therapeutics, Inc.
National Drug Code (NDC)
72426-0818

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.